NCT06093633 is a clinical trial in Sleep Disorder, sponsored by Itamar-Medical, Israel.

Who is sponsoring NCT06093633?

NCT06093633 is sponsored by Itamar-Medical, Israel.

What condition does NCT06093633 study?

NCT06093633 studies Sleep Disorder.

Is NCT06093633 still recruiting?

NCT06093633 is currently recruiting now. Last updated 22 August 2025.

Last reviewed 2025-08-22 · How we verify

NCT06093633

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders

Recruiting now Last updated 22 August 2025

What this trial tests

trial in Sleep Disorder in 600 participants. Currently enrolling.

Timeline

19 September 2022

Primary endpoint
1 October 2025

1 October 2025

Quick facts

Lead sponsor	Itamar-Medical, Israel
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	600
Start date	19 September 2022
Primary completion	1 October 2025
Estimated completion	1 October 2025
Sites	3 locations across United States, Israel

Conditions studied

Sleep Disorder — all drugs for Sleep Disorder →

Sponsor

Itamar-Medical, Israel — full company profile →

Who can join

Adults 12 to 99, any sex, with Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study is a prospective blinded study to collect data regarding the performance of the WP device in detecting sleep disorders. For that purpose, the WP with finger probe and chest sensor will be worn by the subject simultaneous to PSG in a sleep study at the clinical sleep lab. A PSG system will be recording the PSG data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Disorder

Currently open trials in the same condition.

NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
NCT06990256 — Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers · NA · recruiting
NCT04949360 — SleepUp Digital CBTi-based Platform for Insomnia · NA · recruiting
NCT05649514 — Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease · NA · recruiting
NCT06914466 — Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD · recruiting

Other Itamar-Medical, Israel trials

Trials by the same sponsor.

NCT06947447 — WatchPAT SpO2 Validation Study · completed
NCT04249011 — WatchPAT Compared to PSG at 8500' · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06093633 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Itamar-Medical, Israel
Last refreshed: 22 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06093633.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing